This web site is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

ABT-126

AbbVie Inc.

Drug Names(s): ABT-126

Description: ABT-126 is an alpha 7 neuronal nicotinic receptor (NNR) agonist.

ABT-126 News

Pink Sheet FDA Performance Tracker: Breakthrough Therapy Designations

Pink Sheet Deal Watch: AbbVie, arGEN-X To Explore Immuno-Oncology According To GARP

Scrip Tackling Tough-To-Treat Patients As HCV Cure Rates Near 100%

Pink Sheet EASL HCV Highlights: Gilead's Next-Gen Data May Reinforce Market Dominance

Additional information available to subscribers only:

Targets
Routes
Catalysts
Designations
Events

Request a Free Demo Subscriber Login Search for another drug